Sarah is a Partner and patent attorney in our Life Sciences and Chemistry group. Her practice focusses on the field of biotechnology, and she has significant expertise and experience in the areas of synthetic biology, next-generation DNA sequencing technologies, proteomics, diagnostics, medical devices and antibody and TCR technology.
She regularly advises clients in relation to technologies where the life sciences intersects with other fields, including bioinformatics and digital health. For such technologies, an interdisciplinary approach is often required, for example when machine learning and AI are used in the life sciences field, and she enjoys working together with her colleagues across the firm to provide a bespoke experience to clients in these sectors.
Her client base ranges from UK and international academic institutes and startups through to multinationals. Sarah is experienced at handling all stages of the patenting process, from the initial stages of invention capture and drafting patent applications through international prosecution to EPO oppositions and appeals. She ensures that the client’s strategic and commercial goals are considered from the outset.
With nearly 20 years’ experience in the patent profession, Sarah is well-placed to advise on the best IP strategy for each of her clients depending on their individual requirements.
Sarah speaks regularly on aspects of European and UK patent practice and IP issues in relation to the life sciences.